Outstanding Olink Technology backs COVID-19 Research
Supporting research on the COVID-19 pandemic is a mission of primary importance for all actors in the health sector. To this end, Firalis is actively engaged on several fronts to helpthe research by bringing you its expertise through exceptional offers for your pre-clinical and clinical studies related to COVID-19 which will help to better understand and treat the disease. In collaboration with Olink and as an Olink certified service provider, access to Olink Proseek panels are offered at exceptional prices. Each Olink proseek panel allows the simultaneous measurement of 92 markers and are already used in a large number of ongoing and planned COVID-19 studies in North America, Europe and Asia.
Current number of planned/ongoing studies using Olink = 47
To date, Olink is the only available technology capable of accurately measuring more than 1,000 proteins distributed over 13 panels of 92 biomarkers while requiring a total sample volume of less than 50 µl. The method is ideally suited for the discovery of biomarkers, with a mix of well-established and exploratory proteins for a wide range of biological diseases and functions. Proteins of particular interest for COVID-19 research (cytokines, chemokines and proteins with known links to viral infections and acute respiratory conditions, etc.) are listed in the Excel file below (short name, Uniprot ID and panel(s) Olink in which the tests are available).
Firalis is a biotechnology company with a mission to improve disease outcome, therapeutic decisions and generate savings in healthcare through biomarker discovery, development and regulatory qualification that ultimately leads to biomarker-based diagnostics. Firalis is active in the field of drug safety, cardiovascular, inflammatory, neurodegenerative and autoimmune diseases. The company has been awarded with several national and international prizes for its innovative approaches. Firalis Group is certified ISO 13485 (GMP compliant) and ISO 9001 for the development and production of CE-marked assays, certified NF S 96-900 for its biobank and accredited ISO 17025 (GCLP compliant) for testing laboratory.